title: Caveolae from canine airway smooth muscle contain the necessary components for a role in Ca(2+) handling.
abstract: To explain that bronchial smooth muscle undergoes sustained agonist-induced contractions in a Ca(2+)-free medium, we hypothesized that caveolae in the plasma membrane (PM) contain protected Ca(2+). We isolated caveolae from canine tracheal smooth muscle by detergent treatment of PM-derived microsomes. Detergent-resistant membranes were enriched in caveolin-1, a specific marker for caveolae as well as for L-type Ca(2+) channels and Ca(2+) binding proteins (calsequestrin and calreticulin) as determined by Western blotting. Also, the PM Ca(2+) pump was present but not connexin 43 (a noncaveolae PM protein), the sarcoplasmic reticulum (SR) Ca(2+) pump, or the type 1 inositol 1,4, 5-trisphosphate receptor, supporting the idea that SR-derived membranes were not present. Antibodies to caveolin coimmunoprecipitated caveolin with calsequestrin or calreticulin. Thus some of the cellular calsequestrin and calreticulin associated with caveolin on the cytoplasmic face of each caveola. Immunohistochemistry of tracheal smooth muscle crysosections confirmed the localization of caveolin and the PM Ca(2+) pump to the cell periphery, whereas the SR Ca(2+) pump was located deeper in the cell. The presence of L-type Ca(2+) channels, the PM Ca(2+) pump, and the Ca(2+) bindng proteins calsequestrin and calreticulin in caveolin-enriched membranes supports caveola involvement in airway smooth muscle Ca(2+) handling.
authors.affiliation: Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5.
authors.forename: P J
authors.initials: PJ
authors.lastname: Darby
authors.forename: C Y
authors.initials: CY
authors.lastname: Kwan
authors.forename: E E
authors.initials: EE
authors.lastname: Daniel
mesh_terms: D000818:Animals; D064032:Calbindin 2; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000494:pharmacology; D020746:Calcium Channels, L-Type / Q000032:analysis*; D000252:Calcium-Transporting ATPases / Q000032:analysis; D002155:Calsequestrin / Q000032:analysis; D021941:Caveolae / Q000737:chemistry* / Q000201:enzymology; D002462:Cell Membrane / Q000737:chemistry / Q000201:enzymology; D018031:Connexin 43 / Q000032:analysis; D003902:Detergents; D004285:Dogs; D005260:Female; D007150:Immunohistochemistry; D017275:Isradipine / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D008861:Microsomes / Q000737:chemistry / Q000201:enzymology; D009130:Muscle, Smooth / Q000737:chemistry* / Q000378:metabolism; D064030:S100 Calcium Binding Protein G / Q000032:analysis; D012519:Sarcoplasmic Reticulum / Q000737:chemistry / Q000201:enzymology; D016707:Tissue Fixation; D014132:Trachea / Q000737:chemistry* / Q000378:metabolism; D014316:Tritium
chemical_list: D064032:Calbindin 2; D002121:Calcium Channel Blockers; D020746:Calcium Channels, L-Type; D002155:Calsequestrin; D018031:Connexin 43; D003902:Detergents; D064030:S100 Calcium Binding Protein G; D014316:Tritium; D000252:Calcium-Transporting ATPases; D002118:Calcium; D017275:Isradipine